Yiqiong Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yiqiong Yang has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Duo Shen
Department of Gastroenterology, The Affiliated Changzhou Second People’s Hospital of Nanjing Medical University, Changzhou, Jiangsu 213003, China
2 shared publications - Hong Chen
Shaanxi Key Laboratory of Molecular Biology for Agriculture, College of Animal Science and Technology, Northwest A&F University, Yangling, China
1 shared publication - Hongyu Zhao
Department of Clinical Research Center The Second Hospital of Nanjing, Nanjing University of Chinese Medicine Nanjing China
1 shared publication - Jing Wang
Department of Obstetrics and Gynecology, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China
1 shared publication - Jinyun Song
Department of Clinical Research Center The Second Hospital of Nanjing, Nanjing University of Chinese Medicine Nanjing China
1 shared publication Jiyi Zhao
Department of Gastroenterology, Zhongda Hospital, Medical School, Southeast University, Nanjing, Jiangsu 210000, P.R. China
1 shared publication
Latest Publications
- Open Access
- 1 January 2020
- Published by The Korean Gastric Cancer Association in Journal of Gastric Cancer
- Vol. 20 (3) , 300-312
Circular RNA hsa_circ_0005556 Accelerates Gastric Cancer Progression by Sponging miR-4270 to Increase MMP19 Expression
Shen D, et al. J Gastric Cancer. 2019 Sep;20:e28. https://doi.org/10.5230/jgc.2020.20.e28
- 1 January 2020
- Published by The Korean Gastric Cancer Association in Journal of Gastric Cancer
- Vol. 20 (3) , 300-312
Open AccessCircular RNA hsa_circ_0005556 Accelerates Gastric Cancer Progression by Sponging miR-4270 to Increase MMP19 Expression
Shen D, et al. J Gastric Cancer. 2019 Sep;20:e28. https://doi.org/10.5230/jgc.2020.20.e28
- Open Access
- 5 March 2018
- Published by Spandidos Publications in Oncology Letters
- Vol. 15 (5) , 6361-6367
miR-130b-5p promotes proliferation, migration and invasion of gastric cancer cells via targeting RASAL1
The aim of the present study was to investigate the targeted interaction between microRNA (miR)‑130b‑5p and RAS protein activator like 1 (RASAL1) gene and elucidate the function of miR‑130b‑5p in cell proliferation, migration and invasion in gastric cancer. Expression of miR‑130b‑5p and RASAL1 in seven gastric cell lines was detected by reverse transcription-quantitative polymerase chain reaction (RT‑qPCR). MGC803 cells were selected for further study since they exhibited a marked increase in expression of miR‑130b‑5p accompanied by decreased expression of RASAL1. MGC803 cells were transfected with miR‑130b‑5p mimics and miR‑130b‑5p inhibitor using Lipofectamine 2000 for over‑ and underexpression, respectively, with cells transfected with negative control (NC) sequence as the control. In addition, a luciferase reporter gene assay was performed to evaluate the targeted interaction between miR‑130b‑5p and RASAL1. Then, alterations in RASAL1 expression were detected by RT‑qPCR and western blot analysis following transfection with miR‑130b‑5p mimics and miR‑130b‑5p inhibitor. Cell proliferation, colony formation, and migration and invasion ability were detected by MTT, colony formation and Transwell assays, respectively. RASAL1 was demonstrated to be a target gene of miR‑130b‑5p by luciferase reporter gene assay. In addition, the expression of RASAL1 was significantly lower in MGC803 cells that were transfected with miR‑130b‑5p mimics and significantly higher in cells transfected with miR‑130b‑5p inhibitor in comparison with cells transfected with NC (P<0.05). Furthermore, the experimental group transfected with miR‑130b‑5p mimics manifested significantly higher cell proliferation, increased colony formation and increased migratory and invasive capacities (P<0.05). By contrast, cells transfected with miR‑130b‑5p inhibitor exhibited significantly lower cell proliferation, decreased colony formation and decreased migratory and invasive capacities, compared with cells transfected with NC (P<0.05). In conclusion, RASAL1 was demonstrated to be a target gene of miR‑130b‑5p. Overexpression of miR‑130b‑5p results in promoted proliferation, colony formation and migration and invasion abilities through targeted modulation of RASAL1.
- 5 March 2018
- Published by Spandidos Publications in Oncology Letters
- Vol. 15 (5) , 6361-6367
Open AccessmiR-130b-5p promotes proliferation, migration and invasion of gastric cancer cells via targeting RASAL1
The aim of the present study was to investigate the targeted interaction between microRNA (miR)‑130b‑5p and RAS protein activator like 1 (RASAL1) gene and elucidate the function of miR‑130b‑5p in cell proliferation, migration and invasion in gastric cancer. Expression of miR‑130b‑5p and RASAL1 in seven gastric cell lines was detected by reverse transcription-quantitative polymerase chain reaction (RT‑qPCR). MGC803 cells were selected for further study since they exhibited a marked increase in expression of miR‑130b‑5p accompanied by decreased expression of RASAL1. MGC803 cells were transfected with miR‑130b‑5p mimics and miR‑130b‑5p inhibitor using Lipofectamine 2000 for over‑ and underexpression, respectively, with cells transfected with negative control (NC) sequence as the control. In addition, a luciferase reporter gene assay was performed to evaluate the targeted interaction between miR‑130b‑5p and RASAL1. Then, alterations in RASAL1 expression were detected by RT‑qPCR and western blot analysis following transfection with miR‑130b‑5p mimics and miR‑130b‑5p inhibitor. Cell proliferation, colony formation, and migration and invasion ability were detected by MTT, colony formation and Transwell assays, respectively. RASAL1 was demonstrated to be a target gene of miR‑130b‑5p by luciferase reporter gene assay. In addition, the expression of RASAL1 was significantly lower in MGC803 cells that were transfected with miR‑130b‑5p mimics and significantly higher in cells transfected with miR‑130b‑5p inhibitor in comparison with cells transfected with NC (P<0.05). Furthermore, the experimental group transfected with miR‑130b‑5p mimics manifested significantly higher cell proliferation, increased colony formation and increased migratory and invasive capacities (P<0.05). By contrast, cells transfected with miR‑130b‑5p inhibitor exhibited significantly lower cell proliferation, decreased colony formation and decreased migratory and invasive capacities, compared with cells transfected with NC (P<0.05). In conclusion, RASAL1 was demonstrated to be a target gene of miR‑130b‑5p. Overexpression of miR‑130b‑5p results in promoted proliferation, colony formation and migration and invasion abilities through targeted modulation of RASAL1.